Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - Werewolf Therapeutics, Inc. | StockGist | StockGist

Companies
HOWL
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings HOWLSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

Werewolf Therapeutics, Inc.

Filed Feb 11, 2026

Accepted Feb 11, 2026, 12:00 AM ET

CIK 0001785530

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Reporting Person

Werewolf Therapeutics, Inc.

Person Type

OO

CUSIP: 95075A107

Recent Filings

Werewolf Therapeutics, Inc.1 weeks ago

Werewolf Therapeutics, Inc.1 weeks ago

Werewolf Therapeutics, Inc.1 months ago

Werewolf Therapeutics, Inc.1 months ago

Werewolf Therapeutics, Inc.1 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice